Severe neutropenia after rituximab-treatment of multiple sclerosis.


We present here the first MS-case where rituximab-treatment led to grade IV neutropenia, with hospitalization and treatment of a serious infection with broad-spectrum antibiotics. The neutropenia resolved promptly with granulocyte-colony stimulating factor-treatment and the patient recovered well. Due to risk of recurring neutropenia rituximab-treatment was… (More)
DOI: 10.1016/j.msard.2017.12.005


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics